Second Sight Medical Stock Beta
| EYESDelisted Stock | USD 4.14 0.20 4.61% |
Second Sight Medical fundamentals help investors to digest information that contributes to Second Sight's financial success or failures. It also enables traders to predict the movement of Second Stock. The fundamental analysis module provides a way to measure Second Sight's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Second Sight stock.
Second |
Second Sight Medical Company Beta Analysis
Second Sight's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Second Sight Beta | 2.76 |
Most of Second Sight's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Second Sight Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Second Sight Medical has a Beta of 2.76. This is 220.93% higher than that of the Healthcare sector and 165.38% higher than that of the Medical Devices industry. The beta for all United States stocks is notably lower than that of the firm.
Second Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Second Sight's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Second Sight could also be used in its relative valuation, which is a method of valuing Second Sight by comparing valuation metrics of similar companies.Second Sight is currently under evaluation in beta category among related companies.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Second Sight will likely underperform.
Second Fundamentals
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 | |||
| Current Valuation | 11.54 M | |||
| Shares Outstanding | 39.41 M | |||
| Shares Owned By Insiders | 28.61 % | |||
| Shares Owned By Institutions | 7.01 % | |||
| Number Of Shares Shorted | 1.19 M | |||
| Price To Earning | (1.61) X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 616.54 X | |||
| Revenue | 497 K | |||
| Gross Profit | 130 K | |||
| EBITDA | (8.24 M) | |||
| Net Income | (8.29 M) | |||
| Cash And Equivalents | 59.6 M | |||
| Cash Per Share | 1.51 X | |||
| Total Debt | 199 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 25.25 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (10.38 M) | |||
| Short Ratio | 7.36 X | |||
| Earnings Per Share | (0.72) X | |||
| Number Of Employees | 15 | |||
| Beta | 2.76 | |||
| Market Capitalization | 163.15 M | |||
| Total Asset | 28.25 M | |||
| Retained Earnings | (328.85 M) | |||
| Working Capital | 18.78 M | |||
| Current Asset | 26.76 M | |||
| Current Liabilities | 7.98 M |
About Second Sight Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Second Sight Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Second Sight using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Second Sight Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Second Sight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.Moving together with Second Stock
| 0.76 | MDT | Medtronic PLC Financial Report 23rd of May 2024 | PairCorr |
Moving against Second Stock
| 0.68 | BSX | Boston Scientific Corp Earnings Call This Week | PairCorr |
| 0.49 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
| 0.48 | DXCM | DexCom Inc | PairCorr |
| 0.42 | ALGN | Align Technology | PairCorr |
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |